股本结构
单位：万股
| 公告日期 | 2024-02-23 | 2024-02-14 | 2024-02-14 | 2023-12-29 | 2023-12-29 | 2023-05-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 15909.48 | 15909.48 | 15896.66 | 15896.66 | 15885.78 | 14635.78 |
| 普通股本 | 15909.48 | 15909.48 | 15896.66 | 15896.66 | 15885.78 | 14635.78 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-02-20 | 2024-02-10 | 2023-12-31 | 2023-12-27 | 2023-09-30 | 2023-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-02-23 | 15909.48 | 未披露 | 定期报告 | 2024-02-20 |
| 2024-02-14 | 15909.48 | 未披露 | 定期报告 | 2024-02-10 |
| 2024-02-14 | 15896.66 | 未披露 |
更多>>
From September 30, 2023 to December 31, 2023
Issuance of common stock for services
|
2023-12-31 |
| 2023-12-29 | 15896.66 | 未披露 | 定期报告 | 2023-12-27 |
| 2023-12-29 | 15885.78 | 未披露 |
更多>>
From September 30, 2022 to September 30, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of stock options
Issuance of common stock in registered direct offering, net of costs of $1,201,818
|
2023-09-30 |
| 2023-05-05 | 15885.78 | 未披露 |
更多>>
Common Stock offered 12,500,001 shares by the company
|
2023-05-08 |
| 2023-05-12 | 14635.78 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of stock options
|
2023-03-31 |
| 2023-02-10 | 14625.78 | 未披露 | 定期报告 | 2023-02-10 |
| 2022-12-22 | 14621.11 | 未披露 |
更多>>
From September 30, 2021 to September 30, 2022
Issuance of common stock for services
|
2022-09-30 |
| 2022-05-12 | 14612.96 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock for services
|
2022-03-31 |
| 2022-02-10 | 14602.96 | 未披露 |
更多>>
From October 1, 2021 to December 31, 2021
Issuance of common stock for services
|
2021-12-31 |
| 2021-12-15 | 14602.96 | 未披露 | 定期报告 | 2021-11-30 |
| 2021-08-12 | 14597.94 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of warrants
Issuance of common stock upon exercise of stock options
|
2021-06-30 |
| 2021-07-23 | 14497.94 | 未披露 | 定期报告 | 2021-06-25 |
| 2021-05-13 | 13547.39 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-05-13 | 13470.12 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock in private placement offering, net of costs of $1,549,602
Issuance of common stock in registered direct offering, net of costs of $5,520,160
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
|
2021-03-31 |
| 2021-03-26 | 13440.36 | 未披露 | 定期报告 | 2021-03-26 |
| 2021-02-19 | 12578.51 | 未披露 |
更多>>
1.Securities offered 50,830,566 shares of common stock.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering as shown above is based on 74,954,525 shares of common stock issued and outstanding as of February 10, 2021.
|
2021-02-19 |
| 2021-02-11 | 7495.45 | 未披露 | 定期报告 | 2021-02-10 |
| 2021-01-29 | 7103.30 | 未披露 | 定期报告 | 2021-01-27 |
| 2020-12-16 | 5557.70 | 未披露 |
更多>>
From September 30, 2019 to September 30, 2020
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
Issuance of common stock in registered direct offering, net of costs of $622,900
Issuance of common stock in underwritten offering, net of costs of $917,299
|
2020-09-30 |
| 2020-09-11 | 5547.58 | 未披露 | 定期报告 | 2020-09-11 |
| 2020-08-14 | 5547.58 | 未披露 |
更多>>
1.Common stock offered 7,964,804 shares.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering as shown above is based on 46,316,298 shares of common stock issued and outstanding as of June 30, 2020.
|
2020-08-10 |
| 2020-08-14 | 4631.63 | 未披露 |
更多>>
from March 31, 2020 to June 30, 2020
Issuance of common stock for services
Issuance of common stock in registered direct offering, net of costs of $622,900
Issuance of common stock upon exercise of warrants
|
2020-06-30 |
| 2020-05-18 | 4518.69 | 未披露 |
更多>>
Citius Pharmaceuticals Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously announced registered direct offering priced at-the-market under Nasdaq rules. In the offering, Citius sold 7,058,824 shares of its common stock, at a purchase price per share of $1.0625.
|
2020-05-18 |
| 2020-05-14 | 3812.81 | 未披露 | 定期报告 | 2020-05-11 |
| 2020-05-14 | 3807.81 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
|
2020-03-31 |
| 2020-02-13 | 3149.34 | 未披露 | 定期报告 | 2020-02-07 |
| 2020-02-13 | 3017.77 | 未披露 |
更多>>
from September 30, 2019 to December 31, 2019
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
|
2019-12-31 |
| 2019-12-16 | 2893.05 | 未披露 |
更多>>
from September 30, 2018 to September 30, 2019
Issuance of common stock in registered direct offering, net of costs of $466,000
Issuance of common stock in underwritten offering, net of costs of $710,342
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
|
2019-09-30 |
| 2019-09-27 | 2989.70 | 未披露 | 定期报告 | 2019-09-27 |
| 2019-08-14 | 2207.58 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Issuance of common stock in registered direct offering, net of costs of $466,000
|
2019-06-30 |
| 2019-04-17 | 2207.58 | 未披露 | 定期报告 | 2019-04-09 |
| 2019-05-15 | 1864.54 | 未披露 |
更多>>
From December 31, 2018 To March 31, 2019
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
|
2019-03-31 |
| 2019-02-14 | 1852.04 | 未披露 | 定期报告 | 2019-02-08 |
| 2019-02-14 | 1779.88 | 未披露 |
更多>>
From October 1, 2018 To December 31, 2018
Issuance of common stock upon exercise of warrants
|
2018-12-31 |
| 2018-12-20 | 1779.88 | 未披露 | 定期报告 | 2018-11-30 |
| 2018-12-11 | 1619.88 | 未披露 |
更多>>
From September 30, 2017 To September 30, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock, net of issuance costs and underwriting discount of $1,049,999
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
|
2018-09-30 |
| 2018-08-14 | 1619.88 | 未披露 | 定期报告 | 2018-08-13 |
| 2018-08-14 | 1067.72 | 未披露 |
更多>>
From October 1, 2017 to June 30, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
|
2018-06-30 |
| 2018-05-11 | 1067.72 | 未披露 | 定期报告 | 2018-05-08 |
| 2018-05-11 | 1066.72 | 未披露 |
更多>>
From October 1, 2017 to March 31, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
|
2018-03-31 |
| 2018-01-12 | 997.55 | 未披露 | 定期报告 | 2018-01-05 |
| 2018-02-14 | 997.55 | 未披露 |
更多>>
from October 1, 2017 to December 31, 2017
Issuance of common stock in registered direct offering, net of costs of $525,566
Issuance of common stock upon exercise of warrants
Issuance of common stock for release agreement
|
2017-12-31 |
| 2017-12-13 | 842.34 | 未披露 | 定期报告 | 2017-12-01 |
| 2017-11-21 | 842.34 | 未披露 | 定期报告 | 2017-11-20 |
| 2017-12-13 | 834.58 | 未披露 |
更多>>
From September 30, 2016 To September 30, 2017
Issuance of common stock in private placement, net of costs
Issuance of common stock in public offering, net of costs
Issuance of common stock for services and release agreements
Issuance of fractional shares for 1-for-15 reverse stock split
Stock options exercised
Conversion of convertible promissory notes –related party to common stock
|
2017-09-30 |
| 2017-08-14 | 825.28 | 未披露 |
更多>>
On August 8, 2017, Leonard Mazur converted $4,710,000 (which have a carrying value of $5,543,333) of outstanding convertible promissory notes and accrued interest of $76,240 into 1,547,067 shares of common stock at a conversion price per share of $3.09.
On August 8, 2017, the Company closed an underwritten public offering of 1,648,484 shares of common stock and warrants to purchase 1,648,484 shares of common stock at an offering price of $4.125 per share and $0.01 per warrant.
|
2017-08-08 |
| 2017-08-04 | 670.57 | 未披露 | 定期报告 | 2017-08-03 |
| 2017-08-14 | 505.72 | 未披露 |
更多>>
from September 30, 2016 to June 30, 2017
Issuance of common stock in private placements, net of costs
Issuance of common stock for services and release agreements
Issuance of fractional shares for 1-for-15 reverse stock split
Stock options exercised
|
2017-06-30 |
From September 30, 2023 to December 31, 2023
Issuance of common stock for services
From September 30, 2022 to September 30, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of stock options
Issuance of common stock in registered direct offering, net of costs of $1,201,818
Common Stock offered 12,500,001 shares by the company
From December 31, 2022 to March 31, 2023
Issuance of common stock for services
Issuance of common stock upon exercise of stock options
From September 30, 2021 to September 30, 2022
Issuance of common stock for services
From December 31, 2021 to March 31, 2022
Issuance of common stock for services
From October 1, 2021 to December 31, 2021
Issuance of common stock for services
From March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of warrants
Issuance of common stock upon exercise of stock options
From December 31, 2020 to March 31, 2021
Issuance of common stock in private placement offering, net of costs of $1,549,602
Issuance of common stock in registered direct offering, net of costs of $5,520,160
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
1.Securities offered 50,830,566 shares of common stock.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering as shown above is based on 74,954,525 shares of common stock issued and outstanding as of February 10, 2021.
From September 30, 2019 to September 30, 2020
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
Issuance of common stock in registered direct offering, net of costs of $622,900
Issuance of common stock in underwritten offering, net of costs of $917,299
1.Common stock offered 7,964,804 shares.
2.The number of shares of common stock that will be issued and outstanding immediately after this offering as shown above is based on 46,316,298 shares of common stock issued and outstanding as of June 30, 2020.
from March 31, 2020 to June 30, 2020
Issuance of common stock for services
Issuance of common stock in registered direct offering, net of costs of $622,900
Issuance of common stock upon exercise of warrants
Citius Pharmaceuticals Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously announced registered direct offering priced at-the-market under Nasdaq rules. In the offering, Citius sold 7,058,824 shares of its common stock, at a purchase price per share of $1.0625.
From December 31, 2019 to March 31, 2020
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
from September 30, 2019 to December 31, 2019
Issuance of common stock for services
Issuance of common stock upon exercise of warrants
from September 30, 2018 to September 30, 2019
Issuance of common stock in registered direct offering, net of costs of $466,000
Issuance of common stock in underwritten offering, net of costs of $710,342
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
from March 31, 2019 to June 30, 2019
Issuance of common stock in registered direct offering, net of costs of $466,000
From December 31, 2018 To March 31, 2019
Issuance of common stock upon exercise of warrants
Issuance of common stock for services
From October 1, 2018 To December 31, 2018
Issuance of common stock upon exercise of warrants
From September 30, 2017 To September 30, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock, net of issuance costs and underwriting discount of $1,049,999
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
From October 1, 2017 to June 30, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
From October 1, 2017 to March 31, 2018
Issuance of common stock in registered direct offering, net of costs of $760,459
Issuance of common stock upon exercise of warrants
Issuance of common stock for services and release agreement
from October 1, 2017 to December 31, 2017
Issuance of common stock in registered direct offering, net of costs of $525,566
Issuance of common stock upon exercise of warrants
Issuance of common stock for release agreement
From September 30, 2016 To September 30, 2017
Issuance of common stock in private placement, net of costs
Issuance of common stock in public offering, net of costs
Issuance of common stock for services and release agreements
Issuance of fractional shares for 1-for-15 reverse stock split
Stock options exercised
Conversion of convertible promissory notes –related party to common stock
On August 8, 2017, Leonard Mazur converted $4,710,000 (which have a carrying value of $5,543,333) of outstanding convertible promissory notes and accrued interest of $76,240 into 1,547,067 shares of common stock at a conversion price per share of $3.09.
On August 8, 2017, the Company closed an underwritten public offering of 1,648,484 shares of common stock and warrants to purchase 1,648,484 shares of common stock at an offering price of $4.125 per share and $0.01 per warrant.
from September 30, 2016 to June 30, 2017
Issuance of common stock in private placements, net of costs
Issuance of common stock for services and release agreements
Issuance of fractional shares for 1-for-15 reverse stock split
Stock options exercised